Complying with USP Chapters 41 and 1251 revisions for pharma quality control

This webinar focuses on the recent revisions to United States Pharmacopeia (USP) General Chapters 41 and 1251, mandatory since 1 February 2026, and what it means for pharmaceutical quality professionals.

This session features an expert from METTLER TOLEDO with expertise in compliance with regulations when using weighing instruments. He will explain the updated requirements for balances relevant for QC, particularly the key revisions in USP General Chapters 41 and 1251.

Gain expert insight on:

• What’s new in USP 41? Calibration, measurement uncertainty, minimum weight and performance checks
• What’s new in USP 1251? Safety factor concept
• How to fulfil USP 41 and 1251 requirements.

At the end of the webinar our speaker will address specific USP-related questions in a Q&A format.

USP is the single reference work for the quality control of drugs in the United States (Pharma QC). It is therefore also binding for pharmaceutical companies in other regions of the world who export into the US market.